Blueprint Medicines Corp
2019 Q4 - 2025 Q2 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q2 | 8/12/2025 | 327 | 0.0% | 2,552 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 231 | 0.0% | 2,610 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 228 | 0.0% | 2,610 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 310 | 0.0% | 3,351 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 281 | 0.0% | 2,610 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 202 | 0.0% | 2,134 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 702 | 0.0% | 7,609 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 537 | 0.0% | 10,684 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 155 | 0.0% | 2,457 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 76 | 0.0% | 1,682 | 3/31/2023 |
| 2022 Q4 | 2/15/2023 | 59 | 0.0% | 1,347 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 102 | 0.0% | 1,544 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 67 | 0.0% | 1,317 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 39 | 0.0% | 617 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 13 | 0.0% | 120 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 12 | 0.0% | 120 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 107 | 0.0% | 1,211 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 154 | 0.0% | 1,585 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 60 | 0.0% | 535 | 12/31/2020 |
| 2020 Q3 | 10/30/2020 | 54 | 0.0% | 580 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 18 | 0.0% | 235 | 6/30/2020 |
| 2020 Q1 | 4/29/2020 | 27 | 0.0% | 475 | 3/31/2020 |
| 2019 Q4 | 1/17/2020 | 62 | 0.0% | 785 | 12/31/2019 |